Strides Pharma Science Limited (NSE:STAR)
India · Delayed Price · Currency is INR 1,094.10
-17.70 (-1.59%)
Jun 1, 2026, 3:29 PM IST
Strides Pharma Science Market Cap
Strides Pharma Science has a market cap or net worth of 102.48 billion as of June 1, 2026. Its market cap has increased by 74.16% in one year.
Market Cap
102.48B
Enterprise Value
118.34B
Revenue
48.59B
Ranking
n/a
PE Ratio
18.43
Stock Price
1,094.10
Market Cap Chart
Since February 2, 2000, Strides Pharma Science's market cap has increased from 7.49B to 102.48B, an increase of 1,267.47%. That is a compound annual growth rate of 10.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 102.48B | 23.49% |
| Dec 31, 2025 | 82.99B | 36.56% |
| Dec 31, 2024 | 60.77B | 1.87% |
| Dec 29, 2023 | 59.66B | 88.83% |
| Dec 30, 2022 | 31.59B | -21.29% |
| Dec 31, 2021 | 40.14B | -49.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Piramal Pharma | 229.44B |
| Eris Lifesciences | 193.86B |
| NATCO Pharma | 181.96B |
| Cohance Lifesciences | 165.08B |
| Alembic Pharmaceuticals | 144.69B |
| Alivus Life Sciences | 129.55B |
| Sudeep Pharma | 83.82B |
| Akums Drugs and Pharmaceuticals | 80.30B |